Recruitment And Diversity
-
Site Visits 101: Visits Before, Without, And After Trial Participants
10/3/2024
Discover the primary visit types that occur at a clinical research site before, without, and after the presence of clinical trial participants.
-
Site Visits 101: Visits With Participants, From Prescreening To Completion
10/3/2024
Discover all of the clinical research site visits that include patients, from the time they are prescreened to — if enrolled — the time they complete the study.
-
Continuing Rare Disease Treatment With A Compassionate Use Program (CUP)
10/2/2024
Learn how Rezolute successfully led its investigational drug for treating congenital hyperinsulinism (cHI) through a compassionate use program.
-
Compassionate Use Program (CUP) Benefits & Strategies In Rare Disease
10/2/2024
In part two of this series, Rezolute discusses the benefits of continuing patient care with a compassionate use program (CUP) and shares best practices for implementing one.
-
Why Diversity Of Geography Matters: A Call To Drive Rural Patient Enrollment
9/30/2024
To make clinical trials more inclusive, CROs and sponsors must intentionally expand to different — including rural — communities to recruit more diverse patients.
-
Research, Manufacturing, Regulatory, And More: What Are The Challenges With CGTs?
9/27/2024
UCB Head of U.S. Research Roger Palframan discusses the challenges with CGTs — from complex manufacturing to the need for greater and more meaningful patient engagement to evolving regulations and reimbursement.
-
Patients Get More Mileage With Free Flights To Far-Flung Clinical Trial Sites
9/20/2024
LifeLine Pilot Executive Director Lindsey Kerr shares the impact free medical flights can have on patients participating in clinical trials far from home.
-
Why Is The Reality Of Patient Engagement Not Living Up To Its Theory?
9/17/2024
Patient Co-Next's Pauline Frank discusses why pharma knows patient engagement is important but rarely succeeds in implementing it fully.
-
If Sponsors Invite Patients To See The Final Draft Protocol, It's Already Too Late
9/17/2024
Consultant Kamila Novak dives into the importance of early patient input — and why sponsors have a hard time getting it (and implementing it).
-
Why Are We Still Excluding Persons With Disabilities (PWDs) In Clinical Trials?
9/13/2024
Canary Advisors Cofounder and COO Richie Kahn details the National Council on Disability's call for the inclusion of people with disabilities in clinical trials.